Joint pain and osteoarthritis affect over 92 million U.S. adults, and excess body weight is both a primary cause and a major aggravating factor. Every pound of body weight translates to roughly 4 pounds of pressure on your knees during walking. For someone 50 pounds overweight, that means 200 extra pounds of force on each knee with every step. Beyond mechanical stress, excess fat tissue produces inflammatory cytokines that directly damage cartilage and worsen joint inflammation. This creates a debilitating cycle: joint pain limits physical activity, reduced activity causes weight gain, and more weight intensifies the pain.
Clinically proven GLP-1 treatment for Joint Pain & Arthritis. Prescribed by licensed providers, delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Joint Pain & Arthritis is already seeing results
GLP-1 medications (semaglutide and tirzepatide) are clinically proven weight loss treatments for patients with Joint Pain & Arthritis. It affects approximately Over 92 million US adults affected of U.S. adults. Weight Method offers treatment starting at $297/month with virtual consultations and direct shipping.
GLP-1 receptor agonists attack joint pain from multiple angles. The primary benefit is significant weight reduction -- losing 10-20% of body weight dramatically reduces mechanical load on weight-bearing joints. Semaglutide and tirzepatide also appear to have direct anti-inflammatory properties, reducing levels of C-reactive protein and other inflammatory markers that contribute to joint degradation. Patients frequently report improved mobility, reduced pain scores, and the ability to resume physical activities they had previously abandoned. For many, this improved mobility then supports additional weight loss through increased exercise capacity.
If chronic joint pain or arthritis limits your daily activities and you have a BMI of 30 or higher, you are likely a strong candidate for GLP-1 weight loss treatment. Patients with a BMI of 27-29 who have documented joint disease may also qualify. Weight Method considers musculoskeletal conditions as significant comorbidities during eligibility assessment.
Answer a few quick questions to see if you qualify for GLP-1 medication.
Check EligibilityAnswer questions about your health and medical condition.
A provider will review your case and create a personalized plan.
Your GLP-1 medication ships directly to your door.
Clinically proven GLP-1 medications at transparent prices

Same active ingredient as Ozempic® & Wegovy®. Proven to reduce body weight by up to 15%.

Same active ingredient as Mounjaro® & Zepbound®. Dual-action GLP-1/GIP for enhanced results.
Find out if GLP-1 medications can help you lose weight with Joint Pain & Arthritis.
Get Started NowFree consultation. No commitment.